Ch. 15 Liquidator Renews Push For Paul Weiss Docs
The liquidator probing an alleged $355 million insider fraud at a defunct Chinese medical technology company slammed a decision letting Paul Weiss Rifkind Wharton & Garrison LLP and AlixPartners LLP invoke...To view the full article, register now.
Already a subscriber? Click here to view full article